Integrating biology and mathematics to understand checkpoint immunotherapy.

Authors

Rachel S Sousa, Alexander Moshensky, Claire Murat, Shannon N Geels, John Lowengrub, Francesco Marangoni

Published in

Trends in cancer. Sep 22, 2026. Epub Sep 22, 2026.

Abstract

Immune checkpoint inhibitors (ICIs) elicit durable antitumor responses in immunogenic tumors but still fail in most patients. Extensive research has elucidated how ICIs trigger a wide array of antitumor responses, yet, unexpectedly, also fuel tumor immunosuppression, a major driver of therapy failure. We argue that the sheer number of variables at play will hinder upcoming research to improve ICI performance, making the classic experimental approach exceedingly time- and resource-intensive. We posit that this problem can be solved through a bidirectional feedback loop of mathematical modeling and experimental validation. This review consolidates foundational knowledge in cancer immunology and mathematical modeling and proposes strategies that enable mathematicians and immunologists to collaborate fruitfully and expedite breakthroughs in ICI therapy.

PMID:
42850091
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.